hypolipidemic drugs Flashcards
LDL
low density lipoproteins
- transports cholesterol from liver to the blood stream
- aka “bad cholesterol”
- high levels in the blood are associated with an increased risk of atherosclerosis and coronary artery disease
- normal 100 start treatment
HDL
High density lipoprotein
- “good cholesterol”
- HDLs acquire cholesterol from peripheral tissue i.e. arterial walls
- low HDL levels = risk factor for cardiovascular disease
-
LP(a) Lipoprotein
formed from a LDL-like moiety and LP(a) protein
- highly homologous to plasminogen but lacks the ability to be activated by tPA
- repair of vessels
competitive inhibition
has same Vmax different Km
noncompetitive inhibition
has same Km different Vmax (squashed graph)
Cholesterol metabolism
?
statins
simvastatin fluvastatin atorvastatin pravastatin lovastatin
statins use and MOA
- lower LDL levels (by almost 60% ; TG down 40%)
MOA: competitive inhibitors of HMC-CoA reductase - leads to an induction of high affinity LDL receptors–> thus lowering serum LDL levels
- increasing LDL receptors is the important part of the mechanism!!
clinically all statins have the same efficacy
statin side effects
- elevations of serum aminotransferase and hepatotoxicity (increase in liver enzymes ALT/AST)
- myositis (muscle pain), marked by elevated creatine kinase activity
- if drug is not discontinued, rhabdomyolysis may occur–> producing myoglobinemia –> may lead to acute renal failure
*always monitor liver enzymes and creatine kinase when giving statins!
statin drug interactions
- drugs that may inhibit CYP enzymes (erythromycin, ketoconazole) will increase the plasma concentrations of statins
- concomitant use of amiodarone (class 3) or verapamil (class 4) or fibrates causes an increased risk of myopathy
- statin + BABR/ezetimibe (which works better in conjunction with statins)
- never use statins + fibrate bc toxicity! (myositis)
- never combine statins + niacin bc toxicity! (myositis)
niacin
aka nicotinic acid
when used in high doses
Niacin MOA and use
- water soluble VB3 which is converted in the body into nicotinamide adenine dinucleotide (NAD) but in high [ ]
- decreases plasma LDL levels and VLDL **
- markledly decreases plasma TG levels
mechanism primarily involves the inhibition of VLDL synthesis and esterification of Fatty Acids in the liver
Niacin Side Effects
- flushing (PGE2–> vasodilation–> flushing…..treated by aspirin or other NSAIDS)
- diarrhea
- hyperuricemia (can precipitate gout)
- hyperglycemia (so statins are preferred in diabetics)
Fabric Acid Derivatives and use
Gemfibrozil
Fenofibrate
Use: Increases the activity of LPL and Reduces VLDL levels, especially TG!!!
Fenofibrate MOA and use and A/E and drug interactions
MOA: agonist at peroxisome proliferator-activated receptor alpha (PPARalpha) which is a nuclear receptor
- PPARalpha affects genes necessary for carb and fat metabolism –> activation –> increase plasma HDL and decrease plasma TG
- increases the activity of lipoprotein lipase!!
- reduces VLDL levels esp lowers triglycerides
Use: typically used to treat hypertriglyceridemias
(preferred over statins)
A/E:
- GI symptoms
- myopathy (increased with given with statins)
- risk of cholesterol gallstones
Major Drug Interactions:
- fabric acid derivatives can displace other albumin bound drugs like warfarin–> thereby increase the anticoagulant effect of warfarin and sulfonyl ureas
Bile Acid Binding Resins and use
Colestipol
Cholestyramine
Colesevelam
Use: DECREASE LDL levels and INCREASE HDL